Main Sector
Pharma (fully integrated)
Subsectors
Antibodies
Anti-infectives
Biosimilars
Nucleic acid drugs
Proteins
Small molecule therapeutics
Vaccines
Antibody-drug-conjugate
Indications
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Injury, poisoning and certain other consequences of external causes / toxicology
Products
In development: 168
On the market: 40
Description
Genentech, Inc. is a biotechnology company which discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company engages in developing monoclonal antibodies, small molecules, and antibody-drug conjugates that address serious unmet medical needs. The company's product ERIVEDGE (vismodegib) is a hedgehog pathway inhibitor indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally...
